Primary Site >> Colorectal Cancer
Gene >> CSF3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: In vivo tumor growth enhancement by granulocyte colony-stimulating factor. PMID: 1710615 |
Ref: [Combination effect of KW-2228 and aminoglycoside antibiotics on systemic infection in cyclophosphamide-treated tumor-bearing mice]. PMID: 1379653 Ref: Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage- and granulocyte-colony-stimulating factor. PMID: 1380747 |
Ref: Recombinant human granulocyte-colony-stimulating factor (rhg-csf) does not stimulate in-vivo tumor-growth of the human colon-cancer cell-line htb 38 which is responsive in-vitro. PMID: 21573472 |
Ref: Significance of increased neutrophils in patients with advanced colorectal cancer. PMID: 7532422 Ref: Endotoxin (Salmonella abortus equi) in cancer patients. Clinical and immunological findings. PMID: 8524930 |
Ref: Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients. PMID: 8536792 Ref: Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors. PMID: 8648378 Ref: [Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report]. PMID: 8854810 Ref: Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine. PMID: 9816323 |
Ref: Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines. PMID: 9341783 Ref: 9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma. PMID: 9351540 Ref: Clinical experience with CD64-directed immunotherapy. An overview. PMID: 9435876 |
Ref: Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. PMID: 9505898 Ref: Paclitaxel plus gallium nitrate and filgrastim in patients with refractory malignancies: a phase I trial. PMID: 9537208 Ref: High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study. PMID: 9553662 Ref: [Use of filgrastim, granulocyte colony stimulating factor (G-CSF), in radiotherapy to reduce drop-outs because of radiogenic leukopenia]. PMID: 9638171 |
Ref: Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer. PMID: 10071282 Ref: Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. PMID: 10213206 Ref: Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation. PMID: 10214865 |
Ref: A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma. PMID: 11042563 Ref: Medical therapies for ulcerative colitis and Crohn's disease. PMID: 11079045 Ref: A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies. PMID: 11127946 |
Ref: Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical t PMID: 11339498 Ref: Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol for a controlled clinical PMID: 11392607 Ref: Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4). Protocol of a controlled clinical t PMID: 11409486 Ref: Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors. PMID: 11704643 |
Ref: Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs. PMID: 11953891 Ref: Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. PMID: 12059074 Ref: G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. PMID: 12359263 |
Ref: Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer. PMID: 12601545 Ref: A phase I and pharmacologic study of pyrazoloacridine and cisplatin in patients with advanced cancer. PMID: 12795532 Ref: [Selected hematopoietic cytokines in patients with colorectal cancer]. PMID: 14969133 |
Ref: Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. PMID: 15162984 Ref: Effects of G-CSF and antibiotic prophylaxis in a 2 x 2 factorial design on outcome in septic rats. PMID: 15338063 Ref: Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population. PMID: 15338064 Ref: Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate-a novel nonpeptide IL-6 receptor antagonist. PMID: 15381112 Ref: Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis. PMID: 15457367 |
Ref: Expression of granulocyte colony stimulating factor receptor in human colorectal cancer. PMID: 15879049 Ref: Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG). PMID: 16277094 Ref: [Current status and problems in the chemotherapy of our outpatient clinic in the department of clinical oncology]. PMID: 16422473 |
Ref: The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. PMID: 16603145 Ref: Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. PMID: 16904962 Ref: [Reactivity of a novel monoclonal antibody ZCH-2B8a on normal hematopoietic cells and malignant cell lines and its significance]. PMID: 17096904 |
Ref: [Feasibility of modified FOLFIRI regimen for patients with refractory advanced or recurrent colorectal cancer]. PMID: 17301528 Ref: Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial. PMID: 17383527 Ref: [Immunotherapy in radical surgery of colorectal carcinoma]. PMID: 18019635 |
Ref: Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. PMID: 18387976 Ref: Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer. PMID: 18466101 Ref: Neutropenia in 6 ethnic groups from the Caribbean and the U.S. PMID: 18543314 Ref: Granulocyte-colony stimulating factor producing rectal cancer. PMID: 18588705 |
Ref: A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy. PMID: 19092857 Ref: [A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer]. PMID: 20009477 |
Ref: Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines. PMID: 20732287 |
Ref: The perioperative granulocyte/lymphocyte ratio is a clinically relevant marker of surgical stress in patients with colorectal cancer. PMID: 21094053 Ref: Granulocyte colony-stimulating factor-producing ascending colon cancer as indicated by histopathological findings: report of a case. PMID: 22443081 |
Ref: Plasma concentrations of angiogenesis-related molecules in patients with pancreatic cancer. PMID: 22167663 Ref: Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies. PMID: 22674635 Ref: Agranulocytosis from levamisole-adulterated cocaine. PMID: 22773721 Ref: [Effects of qisheng mixture on chemotherapy induced myelosuppression in patients with colorectal cancer]. PMID: 23185750 Ref: Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma. PMID: 23205181 |
Ref: Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium. PMID: 23401226 Ref: The role of pro-inflammatory cytokines and immune cells in colorectal carcinoma progression. PMID: 23599759 Ref: Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. PMID: 23726839 Ref: Circulating midkine in malignant and non-malignant colorectal diseases. PMID: 23899719 Ref: A Type II Arabinogalactan from Anoectochilus formosanus for G-CSF Production in Macrophages and Leukopenia Improvement in CT26-Bearing Mice Treated with 5-Fluorouracil. PMID: 24191166 |
Ref: G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. PMID: 24448357 Ref: Neutropenia and relative dose intensity on adjuvant FOLFOX chemotherapy are not associated with survival for resected colon cancer. PMID: 25012517 Ref: Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels. PMID: 25400792 |
Ref: A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4. PMID: 24469032 Ref: The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy. PMID: 25851633 Ref: Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors. PMID: 25875151 Ref: Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice. PMID: 25976379 Ref: Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses. PMID: 26061815 Ref: The influence of ALA-mediated photodynamic therapy on secretion of selected growth factors by colon cancer cells in hypoxia-like environment in vitro. PMID: 26553325 |
Ref: G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers. PMID: 26797765 Ref: Fever of unknown origin in cancer patients. PMID: 26995082 Ref: Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer. PMID: 27568360 |
Ref: [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology]. PMID: 28471197 Ref: Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps. PMID: 28689023 Ref: Risk of Febrile Neutropenia Associated With Select Myelosuppressive Chemotherapy Regimens in a Large Community-Based Oncology Practice. PMID: 28874597 Ref: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer. PMID: 28881590 Ref: Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies. PMID: 28910204 Ref: Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species. PMID: 29245915 Ref: [Severe Therapy-Related Pancytopenia Caused by UFT and LV in a Patient with Ascending Colon Cancer]. PMID: 29394647 Ref: The safety and clinical efficacy of recombinant human granulocyte colony stimulating factor injection for colon cancer patients undergoing chemotherapy. PMID: 29489977 |
Ref: Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic Regeneration. PMID: 29086459 Ref: Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer. PMID: 29801973 Ref: Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice. PMID: 30270531 Ref: Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients. PMID: 30284380 |